Y6Z-22211-15531
3 vaccinations
6 coded responses
36 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 303 / GA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Survey response — day 0, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: approx 1.5 mm pinpoint bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: 5 mm pinpoint dark bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Skin exfoliation, Skin tightness — Feeling: GoodFree text: Approx 5mm pinpoint bruising at injection site; skin appears a little tight, was peeling prior to lotion, might be related to eczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Approx 5mm pinpoint bruise at injection site, unlikely to be eczema given no itchingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Approx 5 mm pinpoint dark bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — day 7, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Approx 7 mm pinpoint dark bruise at injection site; expanded a bit, has lightened in colourMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-16
- 2021-05-21
- 2021-06-04
- 2021-06-11
- 2021-10-30
-
2022-01-13
Dose 3 — Pfizer-BioNTech
- 2022-01-13
- 2022-01-14
- 2022-01-15
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-02-10
- 2022-02-17
- 2022-02-24
- 2022-04-14
- 2022-07-14
- 2023-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): approx 1.5 mm pinpoint bruise at injection site
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): 5 mm pinpoint dark bruise at injection site
Systemic reaction (other): Approx 5mm pinpoint bruising at injection site; skin appears a little tight, was peeling prior to lotion, might be related to eczema
Systemic reaction (other): Approx 5mm pinpoint bruise at injection site, unlikely to be eczema given no itching
Systemic reaction (other): Approx 5 mm pinpoint dark bruise at injection site
Release 7 — day 7, dose 1
Systemic reaction (other): Approx 7 mm pinpoint dark bruise at injection site; expanded a bit, has lightened in colour
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Skin exfoliation | ✓ | ✓ | ✓ |
| SRO | Skin tightness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release